Summer Street maintained an Neutral rating on ARIAD Pharmaceuticals (NASDAQ: ARIA). A consultant with the firm said there was no ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE